Orange Grove Bio, a drug investment and development firm in the US, has established new strategic collaborations with the Yonsei University Health System (YUHS) and Pohang University of Science and Technology (POSTECH), designed to strengthen the biotechnology entrepreneurial ecosystem in South Korea.

Importantly, these collaborations represent Orange Grove Bio’s first international partnerships, highlighting a strategic geographic expansion of the company’s efforts to harness the significant research potential found in universities and academic medical centers outside of the United States.

Under terms of the partnerships, Orange Grove Bio will work with YUHS and POSTECH to advance the development and commercialisation of novel therapeutics by supporting the translation of scientific discoveries made by researchers within the respective universities.

Orange Grove Bio will work collaboratively with each group to identify and support opportunities for company creation and drug development in the areas of oncology, as well as autoimmune and inflammatory diseases. As part of the effort, Orange Grove Bio will spearhead educational programming and entrepreneurial initiatives for researchers, including faculty and students, at both YUHS and POSTECH.

Specifically, Orange Grove Bio will implement graduate internship programmes at the universities, offering guidance and real-world experience in the biotech industry by working directly with the firm and its portfolio companies.

With these latest academic collaborations, Orange Grove Bio is laying the foundation for serving as a bridge between the biotechnology industries in the US and Korea.